At-home digital diagnostic technology provider Tachmed has appointed Mark Kessler as chief operating officer.

Kessler has extensive C-suite level and operational experience and has managed businesses and teams across the Americas, EMEA and Asia. He worked in a number of senior positions at global asset management firms and investment banks, including Alphadyne Asset Management, Woodbine Capital Advisors, Suranya Capital Partners, and JPMorgan, responsible for global strategy, operational management, risk analysis, compliance, marketing and finance.

Established in 2018, Tachmed develops smart health meters, designed to capture biomarkers of diseases, that disseminates reporting directly through to the clinician and/or other interested parties.

Kessler said: “[Tachmed’s] digital diagnostics system, due to launch in 2023, will seriously disrupt the market and finally allow healthcare providers to deliver a better, fairer and faster service to patients. I am incredibly impressed by the knowledge and expertise of all those working on the platform, and very much look forward to making a positive impact on the business.”

Tachmed’s chief executive Paul Christie commented: “It’s brilliant to have Mark onboard. I know that he will play a vital role in helping us to achieve our aim of bringing safe, easy and affordable digital diagnostic devices to the masses. Our targets for 2023 are certainly ambitious, but I’m certain that we have the right people onboard to ensure we achieve them.” 

Lord Beaverbrook, co-founder and executive chairman at Tachmed added: “Mark is joining the business at a truly exciting time. With the Tachmed digital diagnostics system due to launch later this year, the addition of an experienced COO will undoubtedly help us to achieve our international growth objectives, as well as engaging with new partners and prospective customers.”